Furthermore, previously diagnosed T2DM were excluded in analyses with T2DM as outcome measure, and exclusion of previously diagnosed T2DM in analyses with BCF or insulin sensitivity as outcome measures did not materially affect the results (see Tables S5 and S6). The gene discussed is INS; the disease is type 2 diabetes mellitus.